Deep vein thrombosis resolution is not accelerated with increased neovascularization.

[1]  T. Wakefield,et al.  Neutropenia impairs venous thrombosis resolution in the rat. , 2003, Journal of vascular surgery.

[2]  T. Wakefield,et al.  P-selectin inhibition decreases post-thrombotic vein wall fibrosis in a rat model. , 2003, Surgery.

[3]  L. DiPietro,et al.  Accelerated wound closure in neutrophil‐depleted mice , 2003, Journal of leukocyte biology.

[4]  L. Greenfield,et al.  P-selectin inhibition enhances thrombus resolution and decreases vein wall fibrosis in a rat model. , 2002, Journal of vascular surgery.

[5]  A. Proudfoot.  Chemokine receptors: multifaceted therapeutic targets , 2002, Nature Reviews Immunology.

[6]  J. Fowlkes,et al.  Interleukin-8 administration enhances venous thrombosis resolution in a rat model. , 2001, The Journal of surgical research.

[7]  M. Waltham,et al.  Recruitment of Labelled Monocytes by Experimental Venous Thrombi , 2001, Thrombosis and Haemostasis.

[8]  B. Bennett,et al.  Polymorphonuclear leucocytes mediate endogenous thrombus lysis via a u‐PA‐dependent mechanism , 2001, British journal of haematology.

[9]  M. Waltham,et al.  Vascular endothelial growth factor and basic fibroblast growth factor are found in resolving venous thrombi. , 2000, Journal of vascular surgery.

[10]  J. Ward,et al.  Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression. , 2000, Blood.

[11]  A. Feldman,et al.  The angiogenesis inhibitor, endostatin, does not affect murine cutaneous wound healing. , 2000, The Journal of surgical research.

[12]  T. Wakefield.  Treatment options for venous thrombosis. , 2000, Journal of vascular surgery.

[13]  A. Zlotnik,et al.  The biology of chemokines and their receptors. , 2000, Annual review of immunology.

[14]  J. Wang,et al.  Proinflammatory mediators stimulate neutrophil-directed angiogenesis. , 1999, Archives of surgery.

[15]  M. Burdick,et al.  Neovascularization during venous thrombosis organization: a preliminary study. , 1999, Journal of vascular surgery.

[16]  M. Waltham,et al.  Monocyte chemotactic protein-1 (MCP-1) accelerates the organization and resolution of venous thrombi. , 1999, Journal of vascular surgery.

[17]  J. Isner,et al.  Impaired collateral vessel development associated with reduced expression of vascular endothelial growth factor in ApoE-/- mice. , 1999, Circulation.

[18]  N. Polissar,et al.  Determinants of chronic venous disease after acute deep venous thrombosis. , 1998, Journal of vascular surgery.

[19]  J. Garb,et al.  Basic fibroblast growth factor stimulates angiogenesis in the hindlimb of hyperglycemic rats. , 1998, The Journal of surgical research.

[20]  R. Cardiff,et al.  Delayed wound healing and disorganized neovascularization in transgenic mice expressing the IP-10 chemokine. , 1998, Proceedings of the Association of American Physicians.

[21]  A. Luster,et al.  Chemokines--chemotactic cytokines that mediate inflammation. , 1998, The New England journal of medicine.

[22]  R. Whyte,et al.  The CXC chemokines, IL-8 and IP-10, regulate angiogenic activity in idiopathic pulmonary fibrosis. , 1997, Journal of immunology.

[23]  M. Pepper,et al.  Manipulating angiogenesis. From basic science to the bedside. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[24]  L. Bobrow,et al.  The tissue plasminogen activator and urokinase response in vivo during natural resolution of venous thrombus. , 1995, Journal of vascular surgery.

[25]  M. Shikimori,et al.  The cleavage and inactivation of plasminogen activator inhibitor type 1 by neutrophil elastase: the evaluation of its physiologic relevance in fibrinolysis. , 1995, Blood.

[26]  Cord Sunderkötter,et al.  Macrophages and angiogenesis , 1994, Journal of leukocyte biology.

[27]  T. Standiford,et al.  The immunopathology of chemotactic cytokines: the role of interleukin-8 and monocyte chemoattractant protein-1. , 1994, The Journal of laboratory and clinical medicine.

[28]  G. Stewart,et al.  Neutrophils and deep venous thrombosis. , 1993, Haemostasis.

[29]  R. Strieter,et al.  The immunopathology of chemotactic cytokines. , 1993, Advances in experimental medicine and biology.

[30]  R. Strieter,et al.  Interleukin-8 as a macrophage-derived mediator of angiogenesis. , 1992, Science.

[31]  K. Burnand,et al.  The Response of the Vessel Wall to Thrombosis: The in Vivo Study of Venous Thrombolysis , 1992, Annals of the New York Academy of Sciences.

[32]  P. Walker,et al.  A population based perspective of the hospital incidence and case fatality rates of deep vein thrombosis and pulmonary embolism: The Worcester DVT Study. Anderson FA, Wheeler HB, Goldberg RJ, et al. Arch Intern Med 1991;151:933-8 , 1992 .

[33]  D. Hosmer,et al.  A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. , 1991, Archives of internal medicine.

[34]  E. Kovacs.  Fibrogenic cytokines: the role of immune mediators in the development of scar tissue. , 1991, Immunology today.

[35]  J. W. Moore,et al.  Comparison of the neovascular effects of stimulated macrophages and neutrophils in autologous rabbit corneas. , 1985, The American journal of pathology.

[36]  S. Sevitt.  The vascularisation of deep‐vein thrombi and their fibrous residue: A post‐mortem angiographic study , 1973, The Journal of pathology.